← Back to Clinical Trials
Recruiting NCT06116253
Advanced Diffusion Imaging in Renal Cancer Patients
Trial Parameters
Condition Renal Cancer
Sponsor NYU Langone Health
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex ALL
Min Age 21 Years
Max Age 85 Years
Start Date 2022-12-01
Completion 2028-12-01
Interventions
Magnetic Resonance Imaging (MRI) ScanTc-99m Pentetate
Brief Summary
The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.
Eligibility Criteria
Inclusion Criteria: * Renal mass patients scheduled for laparoscopic partial nephrectomy. * eGFR above 30 ml/min/m2. * Ages 21 to 85 * Must be willing and able to provide consent. Exclusion Criteria: * All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T. * Pregnant women are not eligible for participating in this study. * Acute claustrophobia